Volume 19 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
CHEN Jin-qiang, LI Chun-da, LI Fu-qiang, LU Li-ming, FANG Bin, JIN Zhi-hua. Analysis and treatment of the risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(7): 1131-1134. doi: 10.16766/j.cnki.issn.1674-4152.002003
Citation: CHEN Jin-qiang, LI Chun-da, LI Fu-qiang, LU Li-ming, FANG Bin, JIN Zhi-hua. Analysis and treatment of the risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(7): 1131-1134. doi: 10.16766/j.cnki.issn.1674-4152.002003

Analysis and treatment of the risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis

doi: 10.16766/j.cnki.issn.1674-4152.002003
Funds:

 2020KY990

  • Received Date: 2020-09-09
    Available Online: 2022-02-16
  •   Objective  To explore the risk factors and treatment of spontaneous peritonitis in patients with decompensated liver cirrhosis.  Methods  A total of 120 patients with decompensated liver cirrhosis who were treated in our hospital from January 2011 to December 2019 were divided into the concurrent group and non-complicated group based on whether they were complicated by spontaneous peritonitis (60 cases in each group). Logistic regression analysis was used to analyse the risk factors of spontaneous peritonitis in patients with decompensated liver cirrhosis. According to the different treatment drugs, the concurrent components were divided into the piperacillin and sulbactam group and ceftriaxone group (30 cases in each group). The clinical efficacy and inflammatory factor levels of the two groups were compared.  Results  Univariate analysis showed that the incidence of gastrointestinal bleeding, past history of SBP, Child-Pugh classification, total bilirubin level and blood sodium level had a certain effect on patients with decompensated liver cirrhosis complicated with spontaneous peritonitis (all P < 0.05). Multivariate analysis showed that gastrointestinal bleeding, Child-Pugh classification and total bilirubin levels were independent risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis (OR=0.191, 0.259, 0.922, all P < 0.05). The total effective rate of treatment in the piperacillin and sulbactam group was apparently higher than that in the ceftriaxone group (P < 0.05). After treatment, the levels of serum procalcitonin and C-reactive protein in the two groups were significantly lower than those before treatment (all P < 0.05), and the levels in the piperacillin and sulbactam group were apparently lower than those in the ceftriaxone group (all P < 0.05).  Conclusion  Gastrointestinal bleeding, high Child-Pugh grade and high total bilirubin levels are independent risk factors for spontaneous peritonitis in patients with decompensated liver cirrhosis. Piperacillin and sulbactam can be used in patients with spontaneous peritonitis to reduce the level of inflammatory factors in the body.

     

  • loading
  • [1]
    朱龙川, 甘达凯, 胡青青, 等. 第三代头孢菌素耐药的自发性细菌性腹膜炎发生的预测因素[J]. 临床肝胆病杂志, 2019, 35(7): 1501-1504. doi: 10.3969/j.issn.1001-5256.2019.07.016
    [2]
    李佩波, 秦凡博, 龚建平. 肝硬化患者肠道屏障与细菌易位的关系[J]. 临床肝胆病杂志, 2019, 35(8): 1854-1857. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201908060.htm
    [3]
    吴莹雯, 张桂灵, 姜宏伟, 等. 哌拉西林舒巴坦治疗肝硬化患者自发性细菌性腹膜炎的临床观察[J]. 中国现代医生, 2019, 57(21): 24-27. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201921008.htm
    [4]
    孟樱, 骆欣, 赵国根, 等. 乙肝肝硬化合并自发性细菌性腹膜炎患者血清和腹水中糖链抗原125及降钙素原的变化情况[J]. 中华全科医学, 2017, 15(7): 1239-1241. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201707046.htm
    [5]
    彭官清, 凌乔, 潘沛沛, 等. 肝硬化并发自发性细菌性腹膜炎患者血清中颗粒蛋白前体水平及临床意义[J]. 中华医院感染学杂志, 2019, 29(23): 3558-3562. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201923011.htm
    [6]
    OIKONOMOU T, PAPATHEODORIDIS G V, SAMARKOS M, et al. Clinical impact of microbiome in patients with decompensated cirrhosis[J]. World J Gastroentero, 2018, 24(34): 3813-3820. doi: 10.3748/wjg.v24.i34.3813
    [7]
    YAN D, HUANG Y D, CHEN Y B, et al. Risk factors for Clostridium difficile infection in cirrhotic patients[J]. Hepatobiliary Pancreat Dis Int, 2019, 18(3): 237-241. doi: 10.1016/j.hbpd.2019.04.003
    [8]
    周鹏. 肝硬化患者血清miR-122的表达及与Child-Pugh分级的关系[J]. 中国老年学杂志, 2017, 37(15): 3802-3803. doi: 10.3969/j.issn.1005-9202.2017.15.071
    [9]
    谭志洁, 赵静, 刘文兴, 等. 肝硬化腹水患者并发自发性细菌性腹膜炎病原菌与影响因素分析[J]. 中华医院感染学杂志, 2019, 29(19): 2953-2956. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201919018.htm
    [10]
    RIGHI E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions[J]. World J Gastroentero, 2018, 24(38): 4311-4329. doi: 10.3748/wjg.v24.i38.4311
    [11]
    古川, 宋美怡, 孙文静, 等. 2016年肝硬化领域基础与临床研究进展[J]. 中华肝脏病杂志, 2017, 25(1): 5-8. doi: 10.3760/cma.j.issn.1007-3418.2017.01.003
    [12]
    方亚平, 陈杏林, 刘文芳, 等. 肝硬化腹水合并自发性细菌性腹膜炎的病原学及危险因素分析[J]. 中华医院感染学杂志, 2017, 27(13): 2924-2927. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201713012.htm
    [13]
    顾君娣, 陆佳敏, 江军, 等. 肝硬化腹水患者合并自发性细菌性腹膜炎病原菌及相关因素分析[J]. 中华医院感染学杂志, 2018, 28(19): 2940-2943. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201819016.htm
    [14]
    周小兵, 李玉鑫, 高方媛, 等. 肝硬化合并自发性细菌性腹膜炎133例的危险因素分析[J]. 中华消化杂志, 2019, 39(4): 268-270. doi: 10.3760/cma.j.issn.0254-1432.2019.04.010
    [15]
    熊克宫, 柯坤宇, 孔金峰, 等. 中性粒细胞CD64对自发性细菌性腹膜炎抗生素应用的指导价值[J]. 中国现代医学杂志, 2017, 27(19): 70-73. doi: 10.3969/j.issn.1005-8982.2017.19.014
    [16]
    FIORE M, MARAOLO A E, GENTILE I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review[J]. World J Gastroentero, 2017, 23(25): 4654-4660. doi: 10.3748/wjg.v23.i25.4654
    [17]
    HUANG C H, PANG L T, XU L C, et al. Risk factors, clinical features, and short-term prognosis of spontaneous fungal peritonitis in cirrhosis: A matched case-control study[J]. World J Clin Cases, 2019, 7(17): 2438-2449. doi: 10.12998/wjcc.v7.i17.2438
    [18]
    曾婷, 曾凌, 曹先伟, 等. 耐碳青霉烯类铜绿假单胞菌耐药基因与药敏分析[J]. 中华医院感染学杂志, 2019, 29(20): 3063-3067. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201920006.htm
    [19]
    孙殿静, 代晓茹, 刘晴晴, 等. 舒血宁联合哌拉西林/舒巴坦在2型糖尿病合并下呼吸道感染患者中的应用效果[J]. 中华医院感染学杂志, 2017, 27(10): 2229-2232. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201710018.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Article Metrics

    Article views (184) PDF downloads(2) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return